FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2528704324> ?p ?o ?g. }

• W2528704324 abstract "Abstract Abstract 3923 Background: Autologous transplantation in combination with the newer drugs has significantly prolonged survival of patients with myeloma (MM). However, the majority of patients still relapses. Our previous study has shown that NEK2, a chromosomal instability (CIN) gene, is up-regulated in many types of cancer cells and is highly related to drug resistance. Recently, premature senescence has been determined to be an indicator of the efficacy of anti-cancer drugs. In this study, we investigate the correlation between the inhibition of premature senescence and NEK2 induced drug resistance. Materials and Methods: Four MM cell lines (Δ47, KMS28PE, ARP1 and U266) and 2 other cancer cell lines (MCF7, H1299) over- and under-expressing NEK2 using a lentiviral delivery system were studied. NEK2 induced drug resistance was evaluated by colonogenic and standard apoptotic assays. The phenotypic changes of premature senescence were determined by using SA β-galactosidase (SA β-gal) staining. The mechanisms of NEK2-induced anti-senescence activity were studied in vitro and in the 5TGM1 murine MM mouse model. Results: Over-expression of NEK2 stimulated cancer cells into increased S and G2/M phase, resulting in polyploidy. All NEK2 over-expressing cancer cells were able to override doxorubicin-induced premature senescence and to maintain their proliferative potential. Mechanistic studies revealed that NEK2 activated the PI3K/Akt pathway. This was confirmed by the use of a specific PI3K/Akt inhibitor, KP372-1, which abrogated NEK2-induced drug resistance by decreasing clonogenicity of NEK2 over-expressing cells and by decreasing tumor burden and extending mouse survival in the 5TGM1 myeloma mouse model even better than bortezomib. In contrast, knockdown NEK2 by shRNA also induced premature senescence. We determined that NEK2 activates PI3K/Akt pathway by directly interacting with pp1. And the Akt down-stream targets GSK-3, MDM2, NF-kB and the tumor suppressor genes p53, p21, p27, the pro-apoptotic and pro-survival genes of the Bcl-2 family as well as the ABC transporters that related to drug resistance were identified to contribute to the inhibition of premature senescence resulting in drug resistance. Conclusion: NEK2 inhibits doxorubicin-induced premature senescence, resulting in increased drug resistance by activating the PI3K/Akt pathway. Alternatively, down regulation of NEK2 by shRNA inhibits cell proliferation and decreases drug resistance. Thus, targeting PI3K/Akt pathway should eliminate NEK2 induced drug resistance by re-establishing drug-induced premature senescence. Disclosures: No relevant conflicts of interest to declare." @default.
• W2528704324 created "2016-10-14" @default.
• W2528704324 creator A5002787785 @default.
• W2528704324 creator A5007261675 @default.
• W2528704324 creator A5016853432 @default.
• W2528704324 creator A5056904374 @default.
• W2528704324 creator A5087775484 @default.
• W2528704324 date "2011-11-18" @default.
• W2528704324 modified "2023-09-30" @default.
• W2528704324 title "High Expression of NEK2 Induces Drug Resistance by Inhibiting Premature Senescence Through Activation of the PI3K/Akt Pathway in Myeloma and Other Cancers," @default.
• W2528704324 doi "https://doi.org/10.1182/blood.v118.21.3923.3923" @default.
• W2528704324 hasPublicationYear "2011" @default.
• W2528704324 type Work @default.
• W2528704324 sameAs 2528704324 @default.
• W2528704324 citedByCount "0" @default.
• W2528704324 crossrefType "journal-article" @default.
• W2528704324 hasAuthorship W2528704324A5002787785 @default.
• W2528704324 hasAuthorship W2528704324A5007261675 @default.
• W2528704324 hasAuthorship W2528704324A5016853432 @default.
• W2528704324 hasAuthorship W2528704324A5056904374 @default.
• W2528704324 hasAuthorship W2528704324A5087775484 @default.
• W2528704324 hasConcept C114851261 @default.
• W2528704324 hasConcept C121608353 @default.
• W2528704324 hasConcept C126322002 @default.
• W2528704324 hasConcept C190283241 @default.
• W2528704324 hasConcept C502942594 @default.
• W2528704324 hasConcept C522857546 @default.
• W2528704324 hasConcept C54355233 @default.
• W2528704324 hasConcept C55493867 @default.
• W2528704324 hasConcept C71924100 @default.
• W2528704324 hasConcept C75217442 @default.
• W2528704324 hasConcept C86554907 @default.
• W2528704324 hasConcept C86803240 @default.
• W2528704324 hasConcept C95444343 @default.
• W2528704324 hasConcept C96232424 @default.
• W2528704324 hasConceptScore W2528704324C114851261 @default.
• W2528704324 hasConceptScore W2528704324C121608353 @default.
• W2528704324 hasConceptScore W2528704324C126322002 @default.
• W2528704324 hasConceptScore W2528704324C190283241 @default.
• W2528704324 hasConceptScore W2528704324C502942594 @default.
• W2528704324 hasConceptScore W2528704324C522857546 @default.
• W2528704324 hasConceptScore W2528704324C54355233 @default.
• W2528704324 hasConceptScore W2528704324C55493867 @default.
• W2528704324 hasConceptScore W2528704324C71924100 @default.
• W2528704324 hasConceptScore W2528704324C75217442 @default.
• W2528704324 hasConceptScore W2528704324C86554907 @default.
• W2528704324 hasConceptScore W2528704324C86803240 @default.
• W2528704324 hasConceptScore W2528704324C95444343 @default.
• W2528704324 hasConceptScore W2528704324C96232424 @default.
• W2528704324 hasLocation W25287043241 @default.
• W2528704324 hasOpenAccess W2528704324 @default.
• W2528704324 hasPrimaryLocation W25287043241 @default.
• W2528704324 hasRelatedWork W1748915756 @default.
• W2528704324 hasRelatedWork W1966171598 @default.
• W2528704324 hasRelatedWork W1973188327 @default.
• W2528704324 hasRelatedWork W1982191917 @default.
• W2528704324 hasRelatedWork W1986806498 @default.
• W2528704324 hasRelatedWork W2003274859 @default.
• W2528704324 hasRelatedWork W2042577464 @default.
• W2528704324 hasRelatedWork W2044219470 @default.
• W2528704324 hasRelatedWork W2046947683 @default.
• W2528704324 hasRelatedWork W2049544227 @default.
• W2528704324 hasRelatedWork W2053012209 @default.
• W2528704324 hasRelatedWork W2053283851 @default.
• W2528704324 hasRelatedWork W2076630956 @default.
• W2528704324 hasRelatedWork W2326889380 @default.
• W2528704324 hasRelatedWork W2345908414 @default.
• W2528704324 hasRelatedWork W2509367778 @default.
• W2528704324 hasRelatedWork W2528352078 @default.
• W2528704324 hasRelatedWork W2727619305 @default.
• W2528704324 hasRelatedWork W3038037540 @default.
• W2528704324 hasRelatedWork W3157294974 @default.
• W2528704324 isParatext "false" @default.
• W2528704324 isRetracted "false" @default.
• W2528704324 magId "2528704324" @default.
• W2528704324 workType "article" @default.